Live Chat Software
Optimize Patient Access to Rare Disease Therapies through Promoting Stakeholder Collaboration to Ensure Commercial Success
With the influx of new rare disease therapies gaining approval in the market, the high price of orphan drugs, and unique needs of the rare disease patient population, it is important to develop patient-centric approaches to orphan drug commercialization. The 7th Annual Rare Disease Market Access and Commercialization Summit is an industry-focused event that examines the challenges, innovations, and techniques for achieving commercial success and navigating the reimbursement landscape. Factors such as reimbursement, value determinations, pricing models, financial and clinical support initiatives are discussed from the perspective of key stakeholders, including manufacturers, payers, and advocacy.
- Explore key strategies for rare disease commercialization
- Gain insight into value-based pricing, market access and reimbursement for orphan drugs
- Ensure patient support services for rare disease patient populations
- Understand how to effectively demonstrate value for rare disease therapies
- Accelerate clinical development of orphan drugs to support market access
---Copy.jpg)
